Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Roles of Human CYP2A6 and Monkey CYP2A24 and 2A26 Cytochrome P450 Enzymes in the Oxidation of 2,5,2′,5′-Tetrachlorobiphenyl

Tsutomu Shimada, Kensaku Kakimoto, Shigeo Takenaka, Nobuyuki Koga, Shotaro Uehara, Norie Murayama, Hiroshi Yamazaki, Donghak Kim, F. Peter Guengerich and Masayuki Komori
Drug Metabolism and Disposition December 2016, 44 (12) 1899-1909; DOI: https://doi.org/10.1124/dmd.116.072991
Tsutomu Shimada
Laboratory of Cellular and Molecular Biology, Osaka Prefecture University, Izumisano, Osaka, Japan (T.S., S.T., M.K.); Osaka Prefectural Institute of Public Health, Higashinari-ku, Osaka, Japan (K.K.); Faculty of Nutritional Sciences, Nakamura Gakuen University, Johnan-ku, Fukuoka, Japan (N.K.); Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo, Japan (S.U., N.M., H.Y.); Department of Biological Sciences, Konkuk University, Seoul, South Korea (D.K.); and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee (F.P.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kensaku Kakimoto
Laboratory of Cellular and Molecular Biology, Osaka Prefecture University, Izumisano, Osaka, Japan (T.S., S.T., M.K.); Osaka Prefectural Institute of Public Health, Higashinari-ku, Osaka, Japan (K.K.); Faculty of Nutritional Sciences, Nakamura Gakuen University, Johnan-ku, Fukuoka, Japan (N.K.); Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo, Japan (S.U., N.M., H.Y.); Department of Biological Sciences, Konkuk University, Seoul, South Korea (D.K.); and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee (F.P.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeo Takenaka
Laboratory of Cellular and Molecular Biology, Osaka Prefecture University, Izumisano, Osaka, Japan (T.S., S.T., M.K.); Osaka Prefectural Institute of Public Health, Higashinari-ku, Osaka, Japan (K.K.); Faculty of Nutritional Sciences, Nakamura Gakuen University, Johnan-ku, Fukuoka, Japan (N.K.); Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo, Japan (S.U., N.M., H.Y.); Department of Biological Sciences, Konkuk University, Seoul, South Korea (D.K.); and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee (F.P.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nobuyuki Koga
Laboratory of Cellular and Molecular Biology, Osaka Prefecture University, Izumisano, Osaka, Japan (T.S., S.T., M.K.); Osaka Prefectural Institute of Public Health, Higashinari-ku, Osaka, Japan (K.K.); Faculty of Nutritional Sciences, Nakamura Gakuen University, Johnan-ku, Fukuoka, Japan (N.K.); Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo, Japan (S.U., N.M., H.Y.); Department of Biological Sciences, Konkuk University, Seoul, South Korea (D.K.); and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee (F.P.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shotaro Uehara
Laboratory of Cellular and Molecular Biology, Osaka Prefecture University, Izumisano, Osaka, Japan (T.S., S.T., M.K.); Osaka Prefectural Institute of Public Health, Higashinari-ku, Osaka, Japan (K.K.); Faculty of Nutritional Sciences, Nakamura Gakuen University, Johnan-ku, Fukuoka, Japan (N.K.); Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo, Japan (S.U., N.M., H.Y.); Department of Biological Sciences, Konkuk University, Seoul, South Korea (D.K.); and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee (F.P.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norie Murayama
Laboratory of Cellular and Molecular Biology, Osaka Prefecture University, Izumisano, Osaka, Japan (T.S., S.T., M.K.); Osaka Prefectural Institute of Public Health, Higashinari-ku, Osaka, Japan (K.K.); Faculty of Nutritional Sciences, Nakamura Gakuen University, Johnan-ku, Fukuoka, Japan (N.K.); Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo, Japan (S.U., N.M., H.Y.); Department of Biological Sciences, Konkuk University, Seoul, South Korea (D.K.); and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee (F.P.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Yamazaki
Laboratory of Cellular and Molecular Biology, Osaka Prefecture University, Izumisano, Osaka, Japan (T.S., S.T., M.K.); Osaka Prefectural Institute of Public Health, Higashinari-ku, Osaka, Japan (K.K.); Faculty of Nutritional Sciences, Nakamura Gakuen University, Johnan-ku, Fukuoka, Japan (N.K.); Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo, Japan (S.U., N.M., H.Y.); Department of Biological Sciences, Konkuk University, Seoul, South Korea (D.K.); and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee (F.P.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hiroshi Yamazaki
Donghak Kim
Laboratory of Cellular and Molecular Biology, Osaka Prefecture University, Izumisano, Osaka, Japan (T.S., S.T., M.K.); Osaka Prefectural Institute of Public Health, Higashinari-ku, Osaka, Japan (K.K.); Faculty of Nutritional Sciences, Nakamura Gakuen University, Johnan-ku, Fukuoka, Japan (N.K.); Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo, Japan (S.U., N.M., H.Y.); Department of Biological Sciences, Konkuk University, Seoul, South Korea (D.K.); and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee (F.P.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Peter Guengerich
Laboratory of Cellular and Molecular Biology, Osaka Prefecture University, Izumisano, Osaka, Japan (T.S., S.T., M.K.); Osaka Prefectural Institute of Public Health, Higashinari-ku, Osaka, Japan (K.K.); Faculty of Nutritional Sciences, Nakamura Gakuen University, Johnan-ku, Fukuoka, Japan (N.K.); Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo, Japan (S.U., N.M., H.Y.); Department of Biological Sciences, Konkuk University, Seoul, South Korea (D.K.); and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee (F.P.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masayuki Komori
Laboratory of Cellular and Molecular Biology, Osaka Prefecture University, Izumisano, Osaka, Japan (T.S., S.T., M.K.); Osaka Prefectural Institute of Public Health, Higashinari-ku, Osaka, Japan (K.K.); Faculty of Nutritional Sciences, Nakamura Gakuen University, Johnan-ku, Fukuoka, Japan (N.K.); Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo, Japan (S.U., N.M., H.Y.); Department of Biological Sciences, Konkuk University, Seoul, South Korea (D.K.); and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee (F.P.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Visual Overview

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Abstract

2,5,2′,5′-Tetrachlorobiphenyl (TCB) induced type I binding spectra with cytochrome P450 (P450) 2A6 and 2A13, with Ks values of 9.4 and 0.51 µM, respectively. However, CYP2A6 oxidized 2,5,2′,5′-TCB to form 4-hydroxylated products at a much higher rate (∼1.0 minute−1) than CYP2A13 (∼0.02 minute−1) based on analysis by liquid chromatography–tandem mass spectrometry. Formation of 4-hydroxy-2,5,2′,5′-TCB by CYP2A6 was greater than that of 3-hydroxy-2,5,2′,5′-TCB and three other hydroxylated products. Several human P450 enzymes, including CYP1A1, 1A2, 1B1, 2B6, 2D6, 2E1, 2C9, and 3A4, did not show any detectable activities in oxidizing 2,5,2′,5′-TCB. Cynomolgus monkey CYP2A24, which shows 95% amino acid identity to human CYP2A6, catalyzed 4-hydroxylation of 2,5,2′,5′-TCB at a higher rate (∼0.3 minute−1) than CYP2A26 (93% identity to CYP2A6, ∼0.13 minute−1) and CYP2A23 (94% identity to CYP2A13, ∼0.008 minute−1). None of these human and monkey CYP2A enzymes were catalytically active in oxidizing other TCB congeners, such as 2,4,3′,4′-, 3,4,3′,4′-, and 3,5,3′,5′-TCB. Molecular docking analysis suggested that there are different orientations of interaction of 2,5,2′,5′-TCB with the active sites (over the heme) of human and monkey CYP2A enzymes, and that ligand interaction energies (U values) of bound protein-ligand complexes show structural relationships of interaction of TCBs and other ligands with active sites of CYP2A enzymes. Catalytic differences in human and monkey CYP2A enzymes in the oxidation of 2,5,2′,5′-TCB are suggested to be due to amino acid changes at substrate recognition sites, i.e., V110L, I209S, I300F, V365M, S369G, and R372H, based on the comparison of primary sequences.

Footnotes

    • Received August 2, 2016.
    • Accepted September 12, 2016.
  • T.S., K.K., S.T., and M.K. were supported in part by grants from the Ministry of Education, Science, and Culture of Japan and the Ministry of Health and Welfare of Japan. N.K., S.U., H.Y., and F.P.G. were also supported partly by a Health and Labor Scientific Research Grant [Grant H27-food-designated-017], the Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists B [Grant 15K18934] and Scientific Research [Grant 26460206], and by the United States Public Health Service [Grant R01 GM118122], respectively.

  • dx.doi.org/10.1124/dmd.116.072991.

  • ↵Embedded ImageThis article has supplemental material available at dmd.aspetjournals.org.

  • Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 44 (12)
Drug Metabolism and Disposition
Vol. 44, Issue 12
1 Dec 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Roles of Human CYP2A6 and Monkey CYP2A24 and 2A26 Cytochrome P450 Enzymes in the Oxidation of 2,5,2′,5′-Tetrachlorobiphenyl
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

2,5,2′,5′-Tetrachlorobiphenyl by Human and Monkey CYP2A Enzymes

Tsutomu Shimada, Kensaku Kakimoto, Shigeo Takenaka, Nobuyuki Koga, Shotaro Uehara, Norie Murayama, Hiroshi Yamazaki, Donghak Kim, F. Peter Guengerich and Masayuki Komori
Drug Metabolism and Disposition December 1, 2016, 44 (12) 1899-1909; DOI: https://doi.org/10.1124/dmd.116.072991

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

2,5,2′,5′-Tetrachlorobiphenyl by Human and Monkey CYP2A Enzymes

Tsutomu Shimada, Kensaku Kakimoto, Shigeo Takenaka, Nobuyuki Koga, Shotaro Uehara, Norie Murayama, Hiroshi Yamazaki, Donghak Kim, F. Peter Guengerich and Masayuki Komori
Drug Metabolism and Disposition December 1, 2016, 44 (12) 1899-1909; DOI: https://doi.org/10.1124/dmd.116.072991
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Overview
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Adipocyte PXR does not play an essential role in obesity.
  • CYP3A-mediated oxidation of DABE and BIBR0951
  • Biodistribution of Lipid in Rats
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics